Main menu

Resolving MiSeq-generated ambiguities in HLA-DPB1 typing by using the Oxford Nanopore technology


The technical limitations of current next-generation sequencing technologies, combined with an ever-increasing number of human leukocyte antigen (HLA) alleles, forms the basis for the additional ambiguities we encounter in our clinical practice at an increasing rate. HLA-DPB1 characterization, particularly, generates a significant percent of ambiguities (25.5%) posing a challenge for accurate and unambiguous HLA-DPB1 genotyping. Phasing of exonic heterozygous positions between exon 2 and all other downstream exons has been the major cause of ambiguities. In this study, Oxford Nanopore, a third generation sequencing technology, was used to resolve the phasing. The accurate MiSeq sequencing data combined with the long reads obtained from the MinION platform of Nanopore technology allowed for the resolution of the tested ambiguities.

Authors: Jamie L. Duke, Timothy L. Mosbruger, Deborah Ferriola, Nilesh Chitnis, Taishan Hu, Nikolaos Tairis, David J. Margolis, Dimitri S. Monos

入门指南

购买 MinION 启动包 Nanopore 商城 测序服务提供商 全球代理商

联系我们

Intellectual property Cookie policy Corporate reporting Privacy policy Terms & conditions Accessibility

关于 Oxford Nanopore

Contact us 领导团队 媒体资源和联系方式 投资者 在 Oxford Nanopore 工作 BSI 27001 accreditationBSI 90001 accreditationBSI mark of trust
Chinese flag